 ?您的位置：對(duì)照品 > 標(biāo)準(zhǔn)物質(zhì) > 計(jì)量院標(biāo)準(zhǔn)物質(zhì) > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：B692260 |
| 產(chǎn)品名稱：N-(4-((1R,3R)-3-((tert-Butyldimethylsilyl)oxy)-1-cyanocyclopentyl)phenyl)-2-chloronicotina |
| 產(chǎn)品CAS： |
| 規(guī)格含量：5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
B692260 |
| 名稱: |
N-(4-((1R,3R)-3-((tert-Butyldimethylsilyl)oxy)-1-cyanocyclopentyl)phenyl)-2-chloronicotinamide |
| 分子式: |
C??H??ClN?O?Si |
| 外觀: |
Pale Yellow Powder |
| 分子量: |
456.05 |
| 溶解度: |
Chloroform, Methanol |
| 類別: |
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
N-(4-((1R,3R)-3-((tert-Butyldimethylsilyl)oxy)-1-cyanocyclopentyl)phenyl)-2-chloronicotinamide is an impurity in the synthesis of metabolites of the antiangiogenic agent and selective VEGFR2 inhibitor Apatinib (A726150). |
| 參考文獻(xiàn) |
|
|
|
|
|
|
